NBTX
Nanobiotix
NASDAQ: NBTX · HEALTHCARE · BIOTECHNOLOGY
$32.99
-0.39% today
Updated 2026-04-29
Market cap
$1.60B
P/E ratio
—
P/S ratio
49.09x
EPS (TTM)
$-0.59
Dividend yield
—
52W range
$3 – $42
Volume
0.1M
Nanobiotix (NBTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-73.50%
Operating margin
-196.40%
ROE
-198.70%
ROA
-10.10%
Debt/equity
-0.74x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | $1.36M | $-5.25M | 100.00% | -384.27% | -385.69% |
| 2012 | $970608.00 | $-5.33M | 100.00% | -530.89% | -549.23% |
| 2013 | $1.60M | $-8.14M | 100.00% | -512.67% | -510.50% |
| 2014 | $2.77M | $-9.56M | 100.00% | -347.18% | -344.90% |
| 2015 | $4.02M | $-17.00M | 100.00% | -426.92% | -423.46% |
| 2016 | $5.42M | $-21.88M | 100.00% | -403.10% | -403.58% |
| 2017 | $3.72M | $-26.14M | 100.00% | -678.86% | -702.39% |
| 2018 | $3.48M | $-30.34M | 100.00% | -864.24% | -872.23% |
| 2019 | $2.54M | $-50.91M | 100.00% | -1,840.97% | -2,003.74% |
| 2020 | $2.33M | $-33.59M | 100.00% | -1,566.80% | -1,444.73% |
| 2021 | $2.65M | $-47.00M | 100.00% | -1,986.36% | -1,775.71% |
| 2022 | $4.78M | $-57.04M | 100.00% | -977.85% | -1,194.33% |
| 2023 | $36.21M | $-39.70M | 100.00% | -73.96% | -109.64% |
| 2024 | $-7.19M | $-68.13M | 100.00% | 951.21% | 947.59% |
| 2025 | $29.64M | $-23.96M | 100.00% | -36.49% | -80.83% |